nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—CYP3A4—bone cancer	0.907	1	CbGaD
Flunisolide—Fluocinonide—SMO—bone cancer	0.00389	0.404	CrCbGaD
Flunisolide—Ocular discomfort—Methotrexate—bone cancer	0.00262	0.0313	CcSEcCtD
Flunisolide—Pleurisy—Methotrexate—bone cancer	0.00244	0.0291	CcSEcCtD
Flunisolide—Ageusia—Cisplatin—bone cancer	0.00134	0.016	CcSEcCtD
Flunisolide—Rhinorrhoea—Cisplatin—bone cancer	0.00134	0.016	CcSEcCtD
Flunisolide—Infection—Carboplatin—bone cancer	0.00131	0.0157	CcSEcCtD
Flunisolide—Pain—Carboplatin—bone cancer	0.00113	0.0135	CcSEcCtD
Flunisolide—Wheezing—Cisplatin—bone cancer	0.00105	0.0126	CcSEcCtD
Flunisolide—Body temperature increased—Carboplatin—bone cancer	0.00104	0.0125	CcSEcCtD
Flunisolide—Oral candidiasis—Epirubicin—bone cancer	0.000877	0.0105	CcSEcCtD
Flunisolide—Nasal congestion—Cisplatin—bone cancer	0.000864	0.0103	CcSEcCtD
Flunisolide—Hypokinesia—Epirubicin—bone cancer	0.000825	0.00986	CcSEcCtD
Flunisolide—Oral candidiasis—Doxorubicin—bone cancer	0.000811	0.00969	CcSEcCtD
Flunisolide—Laryngitis—Epirubicin—bone cancer	0.000773	0.00923	CcSEcCtD
Flunisolide—Hypokinesia—Doxorubicin—bone cancer	0.000763	0.00912	CcSEcCtD
Flunisolide—Irritability—Cisplatin—bone cancer	0.000751	0.00898	CcSEcCtD
Flunisolide—Laryngitis—Doxorubicin—bone cancer	0.000715	0.00854	CcSEcCtD
Flunisolide—Nasopharyngitis—Cisplatin—bone cancer	0.000704	0.00841	CcSEcCtD
Flunisolide—Stinging—Epirubicin—bone cancer	0.000687	0.00821	CcSEcCtD
Flunisolide—Ageusia—Epirubicin—bone cancer	0.000687	0.00821	CcSEcCtD
Flunisolide—Dysphonia—Epirubicin—bone cancer	0.000677	0.00809	CcSEcCtD
Flunisolide—Abdominal discomfort—Cisplatin—bone cancer	0.000652	0.00779	CcSEcCtD
Flunisolide—Glossitis—Methotrexate—bone cancer	0.000646	0.00772	CcSEcCtD
Flunisolide—Stinging—Doxorubicin—bone cancer	0.000636	0.0076	CcSEcCtD
Flunisolide—Ageusia—Doxorubicin—bone cancer	0.000636	0.0076	CcSEcCtD
Flunisolide—Dysphonia—Doxorubicin—bone cancer	0.000626	0.00748	CcSEcCtD
Flunisolide—Cough increased—Epirubicin—bone cancer	0.000608	0.00727	CcSEcCtD
Flunisolide—Lacrimation increased—Epirubicin—bone cancer	0.000604	0.00722	CcSEcCtD
Flunisolide—Glossitis—Epirubicin—bone cancer	0.000604	0.00722	CcSEcCtD
Flunisolide—Vaginal inflammation—Methotrexate—bone cancer	0.000595	0.00711	CcSEcCtD
Flunisolide—Stomatitis—Cisplatin—bone cancer	0.000591	0.00706	CcSEcCtD
Flunisolide—Conjunctivitis—Cisplatin—bone cancer	0.00059	0.00705	CcSEcCtD
Flunisolide—Neck pain—Epirubicin—bone cancer	0.000564	0.00673	CcSEcCtD
Flunisolide—Cough increased—Doxorubicin—bone cancer	0.000563	0.00673	CcSEcCtD
Flunisolide—Vaginal infection—Methotrexate—bone cancer	0.000562	0.00671	CcSEcCtD
Flunisolide—Lacrimation increased—Doxorubicin—bone cancer	0.000559	0.00668	CcSEcCtD
Flunisolide—Glossitis—Doxorubicin—bone cancer	0.000559	0.00668	CcSEcCtD
Flunisolide—Vaginal inflammation—Epirubicin—bone cancer	0.000557	0.00665	CcSEcCtD
Flunisolide—Candida infection—Epirubicin—bone cancer	0.000532	0.00635	CcSEcCtD
Flunisolide—Vaginal infection—Epirubicin—bone cancer	0.000526	0.00628	CcSEcCtD
Flunisolide—Neck pain—Doxorubicin—bone cancer	0.000521	0.00623	CcSEcCtD
Flunisolide—Vaginal inflammation—Doxorubicin—bone cancer	0.000515	0.00616	CcSEcCtD
Flunisolide—Budesonide—CYP3A4—bone cancer	0.000512	0.0531	CrCbGaD
Flunisolide—Lymphadenopathy—Methotrexate—bone cancer	0.000506	0.00605	CcSEcCtD
Flunisolide—Fluticasone furoate—CYP3A4—bone cancer	0.000502	0.0521	CrCbGaD
Flunisolide—Candida infection—Doxorubicin—bone cancer	0.000492	0.00588	CcSEcCtD
Flunisolide—Vaginal infection—Doxorubicin—bone cancer	0.000486	0.00581	CcSEcCtD
Flunisolide—Malnutrition—Cisplatin—bone cancer	0.000474	0.00566	CcSEcCtD
Flunisolide—Lymphadenopathy—Epirubicin—bone cancer	0.000474	0.00566	CcSEcCtD
Flunisolide—Eczema—Epirubicin—bone cancer	0.00045	0.00537	CcSEcCtD
Flunisolide—Vision blurred—Cisplatin—bone cancer	0.000447	0.00534	CcSEcCtD
Flunisolide—Tremor—Cisplatin—bone cancer	0.000444	0.00531	CcSEcCtD
Flunisolide—Alclometasone—CYP3A4—bone cancer	0.000441	0.0458	CrCbGaD
Flunisolide—Ill-defined disorder—Cisplatin—bone cancer	0.00044	0.00526	CcSEcCtD
Flunisolide—Lymphadenopathy—Doxorubicin—bone cancer	0.000438	0.00524	CcSEcCtD
Flunisolide—Increased appetite—Epirubicin—bone cancer	0.00043	0.00514	CcSEcCtD
Flunisolide—Malaise—Cisplatin—bone cancer	0.000427	0.00511	CcSEcCtD
Flunisolide—Paramethasone—CYP3A4—bone cancer	0.000424	0.044	CrCbGaD
Flunisolide—Ciclesonide—CYP3A4—bone cancer	0.000417	0.0433	CrCbGaD
Flunisolide—Eczema—Doxorubicin—bone cancer	0.000416	0.00497	CcSEcCtD
Flunisolide—Fluorometholone—CYP3A4—bone cancer	0.000414	0.0429	CrCbGaD
Flunisolide—Irritability—Methotrexate—bone cancer	0.000412	0.00493	CcSEcCtD
Flunisolide—Myalgia—Cisplatin—bone cancer	0.000404	0.00482	CcSEcCtD
Flunisolide—Anxiety—Cisplatin—bone cancer	0.000402	0.00481	CcSEcCtD
Flunisolide—Methylprednisolone—CYP3A4—bone cancer	0.0004	0.0415	CrCbGaD
Flunisolide—Discomfort—Cisplatin—bone cancer	0.000399	0.00476	CcSEcCtD
Flunisolide—Increased appetite—Doxorubicin—bone cancer	0.000398	0.00476	CcSEcCtD
Flunisolide—Migraine—Epirubicin—bone cancer	0.000398	0.00475	CcSEcCtD
Flunisolide—Oedema—Cisplatin—bone cancer	0.000387	0.00462	CcSEcCtD
Flunisolide—Infection—Cisplatin—bone cancer	0.000384	0.00459	CcSEcCtD
Flunisolide—Tachycardia—Cisplatin—bone cancer	0.000378	0.00451	CcSEcCtD
Flunisolide—Hyperhidrosis—Cisplatin—bone cancer	0.000374	0.00447	CcSEcCtD
Flunisolide—Migraine—Doxorubicin—bone cancer	0.000368	0.0044	CcSEcCtD
Flunisolide—Nasopharyngitis—Epirubicin—bone cancer	0.000361	0.00432	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—bone cancer	0.000358	0.00428	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000352	0.00421	CcSEcCtD
Flunisolide—Abdominal distension—Epirubicin—bone cancer	0.000352	0.0042	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—bone cancer	0.000347	0.00415	CcSEcCtD
Flunisolide—Dyspnoea—Cisplatin—bone cancer	0.000345	0.00412	CcSEcCtD
Flunisolide—Triamcinolone—CYP3A4—bone cancer	0.000337	0.035	CrCbGaD
Flunisolide—Decreased appetite—Cisplatin—bone cancer	0.000336	0.00402	CcSEcCtD
Flunisolide—Bronchitis—Epirubicin—bone cancer	0.000336	0.00401	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—bone cancer	0.000335	0.004	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—bone cancer	0.000334	0.004	CcSEcCtD
Flunisolide—Pain—Cisplatin—bone cancer	0.000331	0.00395	CcSEcCtD
Flunisolide—Triamcinolone—PTGS2—bone cancer	0.00033	0.0343	CrCbGaD
Flunisolide—Abdominal distension—Doxorubicin—bone cancer	0.000325	0.00389	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Epirubicin—bone cancer	0.000325	0.00388	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—bone cancer	0.000324	0.00388	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—bone cancer	0.000324	0.00387	CcSEcCtD
Flunisolide—Sweating—Methotrexate—bone cancer	0.000319	0.00381	CcSEcCtD
Flunisolide—Feeling abnormal—Cisplatin—bone cancer	0.000319	0.00381	CcSEcCtD
Flunisolide—Weight increased—Epirubicin—bone cancer	0.000318	0.0038	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—bone cancer	0.000314	0.00375	CcSEcCtD
Flunisolide—Pneumonia—Epirubicin—bone cancer	0.000313	0.00374	CcSEcCtD
Flunisolide—Bronchitis—Doxorubicin—bone cancer	0.000311	0.00371	CcSEcCtD
Flunisolide—Prednisone—CYP3A4—bone cancer	0.000306	0.0317	CrCbGaD
Flunisolide—Body temperature increased—Cisplatin—bone cancer	0.000306	0.00365	CcSEcCtD
Flunisolide—Stomatitis—Epirubicin—bone cancer	0.000304	0.00363	CcSEcCtD
Flunisolide—Conjunctivitis—Epirubicin—bone cancer	0.000303	0.00362	CcSEcCtD
Flunisolide—Urinary tract infection—Epirubicin—bone cancer	0.000303	0.00362	CcSEcCtD
Flunisolide—Fluticasone Propionate—CYP3A4—bone cancer	0.000302	0.0313	CrCbGaD
Flunisolide—Upper respiratory tract infection—Doxorubicin—bone cancer	0.0003	0.00359	CcSEcCtD
Flunisolide—Sweating—Epirubicin—bone cancer	0.000299	0.00357	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—bone cancer	0.000297	0.00354	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—bone cancer	0.000294	0.00352	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—bone cancer	0.000294	0.00351	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—bone cancer	0.000292	0.00349	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—bone cancer	0.00029	0.00346	CcSEcCtD
Flunisolide—Hypersensitivity—Cisplatin—bone cancer	0.000285	0.00341	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—bone cancer	0.000283	0.00338	CcSEcCtD
Flunisolide—Prednisolone—CYP3A4—bone cancer	0.000282	0.0293	CrCbGaD
Flunisolide—Stomatitis—Doxorubicin—bone cancer	0.000281	0.00336	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—bone cancer	0.00028	0.00335	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—bone cancer	0.00028	0.00335	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—bone cancer	0.00028	0.00335	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—bone cancer	0.000278	0.00332	CcSEcCtD
Flunisolide—Asthenia—Cisplatin—bone cancer	0.000278	0.00332	CcSEcCtD
Flunisolide—Pharyngitis—Epirubicin—bone cancer	0.000278	0.00332	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—bone cancer	0.000276	0.0033	CcSEcCtD
Flunisolide—Betamethasone—CYP3A4—bone cancer	0.000276	0.0287	CrCbGaD
Flunisolide—Oedema peripheral—Epirubicin—bone cancer	0.000275	0.00329	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—bone cancer	0.000272	0.00325	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—bone cancer	0.00027	0.0281	CrCbGaD
Flunisolide—Sinusitis—Doxorubicin—bone cancer	0.00027	0.00323	CcSEcCtD
Flunisolide—Chills—Methotrexate—bone cancer	0.000268	0.0032	CcSEcCtD
Flunisolide—Diarrhoea—Cisplatin—bone cancer	0.000265	0.00316	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—bone cancer	0.000264	0.00316	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—bone cancer	0.00026	0.00311	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—bone cancer	0.000259	0.0031	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—bone cancer	0.000257	0.00308	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—bone cancer	0.000257	0.00307	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—bone cancer	0.000255	0.00305	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—bone cancer	0.000255	0.00304	CcSEcCtD
Flunisolide—Back pain—Methotrexate—bone cancer	0.000252	0.00301	CcSEcCtD
Flunisolide—Chills—Epirubicin—bone cancer	0.000251	0.003	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—bone cancer	0.000246	0.00294	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—bone cancer	0.000245	0.00293	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—bone cancer	0.000245	0.00292	CcSEcCtD
Flunisolide—Rash—Cisplatin—bone cancer	0.000244	0.00291	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—bone cancer	0.000244	0.00291	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—bone cancer	0.000243	0.00291	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—bone cancer	0.000241	0.00288	CcSEcCtD
Flunisolide—Dysgeusia—Epirubicin—bone cancer	0.000238	0.00285	CcSEcCtD
Flunisolide—Back pain—Epirubicin—bone cancer	0.000235	0.00281	CcSEcCtD
Flunisolide—Malaise—Methotrexate—bone cancer	0.000235	0.0028	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—bone cancer	0.000234	0.00279	CcSEcCtD
Flunisolide—Chills—Doxorubicin—bone cancer	0.000232	0.00277	CcSEcCtD
Flunisolide—Nausea—Cisplatin—bone cancer	0.00023	0.00275	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—bone cancer	0.000229	0.00274	CcSEcCtD
Flunisolide—Cough—Methotrexate—bone cancer	0.000227	0.00271	CcSEcCtD
Flunisolide—Ill-defined disorder—Epirubicin—bone cancer	0.000226	0.0027	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—bone cancer	0.000225	0.00269	CcSEcCtD
Flunisolide—Agitation—Epirubicin—bone cancer	0.000224	0.00267	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—bone cancer	0.000221	0.00265	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—bone cancer	0.000221	0.00265	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—bone cancer	0.000221	0.00264	CcSEcCtD
Flunisolide—Malaise—Epirubicin—bone cancer	0.00022	0.00262	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—bone cancer	0.000219	0.00261	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—bone cancer	0.000219	0.00261	CcSEcCtD
Flunisolide—Syncope—Epirubicin—bone cancer	0.000218	0.00261	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—bone cancer	0.000218	0.0026	CcSEcCtD
Flunisolide—Hydrocortisone—CYP3A4—bone cancer	0.000216	0.0224	CrCbGaD
Flunisolide—Palpitations—Epirubicin—bone cancer	0.000215	0.00257	CcSEcCtD
Flunisolide—Loss of consciousness—Epirubicin—bone cancer	0.000214	0.00256	CcSEcCtD
Flunisolide—Cough—Epirubicin—bone cancer	0.000212	0.00254	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—bone cancer	0.000212	0.00254	CcSEcCtD
Flunisolide—Infection—Methotrexate—bone cancer	0.000211	0.00252	CcSEcCtD
Flunisolide—Hypertension—Epirubicin—bone cancer	0.00021	0.00251	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—bone cancer	0.000209	0.0025	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—bone cancer	0.000207	0.00248	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—bone cancer	0.000207	0.00248	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—bone cancer	0.000207	0.00247	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—bone cancer	0.000207	0.00247	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—bone cancer	0.000205	0.00245	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—bone cancer	0.000205	0.00245	CcSEcCtD
Flunisolide—Malaise—Doxorubicin—bone cancer	0.000203	0.00243	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—bone cancer	0.000202	0.00242	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—bone cancer	0.000202	0.00241	CcSEcCtD
Flunisolide—Palpitations—Doxorubicin—bone cancer	0.000199	0.00238	CcSEcCtD
Flunisolide—Oedema—Epirubicin—bone cancer	0.000199	0.00237	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—bone cancer	0.000198	0.00237	CcSEcCtD
Flunisolide—Infection—Epirubicin—bone cancer	0.000197	0.00236	CcSEcCtD
Flunisolide—Cough—Doxorubicin—bone cancer	0.000197	0.00235	CcSEcCtD
Flunisolide—Shock—Epirubicin—bone cancer	0.000195	0.00234	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—bone cancer	0.000194	0.00232	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—bone cancer	0.000194	0.00232	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000193	0.00231	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—bone cancer	0.000192	0.00229	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—bone cancer	0.000192	0.00229	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—bone cancer	0.000192	0.00229	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—bone cancer	0.000192	0.00229	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—bone cancer	0.000191	0.00228	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—bone cancer	0.000189	0.00226	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—bone cancer	0.000189	0.00226	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—bone cancer	0.000187	0.00223	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—bone cancer	0.000185	0.00221	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—bone cancer	0.000184	0.0022	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—bone cancer	0.000183	0.00219	CcSEcCtD
Flunisolide—Infection—Doxorubicin—bone cancer	0.000183	0.00218	CcSEcCtD
Flunisolide—Pain—Methotrexate—bone cancer	0.000182	0.00217	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000181	0.00216	CcSEcCtD
Flunisolide—Shock—Doxorubicin—bone cancer	0.000181	0.00216	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—bone cancer	0.00018	0.00215	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—bone cancer	0.000179	0.00214	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—bone cancer	0.000178	0.00212	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—bone cancer	0.000177	0.00212	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—bone cancer	0.000175	0.00209	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—bone cancer	0.000175	0.00209	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—bone cancer	0.000174	0.00207	CcSEcCtD
Flunisolide—Decreased appetite—Epirubicin—bone cancer	0.000173	0.00206	CcSEcCtD
Flunisolide—Fatigue—Epirubicin—bone cancer	0.000171	0.00205	CcSEcCtD
Flunisolide—Constipation—Epirubicin—bone cancer	0.00017	0.00203	CcSEcCtD
Flunisolide—Pain—Epirubicin—bone cancer	0.00017	0.00203	CcSEcCtD
Flunisolide—Urticaria—Methotrexate—bone cancer	0.000169	0.00202	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—bone cancer	0.000168	0.00201	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—bone cancer	0.000168	0.00201	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000167	0.002	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—bone cancer	0.000166	0.00199	CcSEcCtD
Flunisolide—Dyspnoea—Doxorubicin—bone cancer	0.000164	0.00196	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—bone cancer	0.000164	0.00196	CcSEcCtD
Flunisolide—Gastrointestinal pain—Epirubicin—bone cancer	0.000162	0.00194	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—bone cancer	0.000162	0.00193	CcSEcCtD
Flunisolide—Dexamethasone—CYP3A4—bone cancer	0.000161	0.0167	CrCbGaD
Flunisolide—Decreased appetite—Doxorubicin—bone cancer	0.00016	0.00191	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—bone cancer	0.000158	0.00189	CcSEcCtD
Flunisolide—Urticaria—Epirubicin—bone cancer	0.000158	0.00189	CcSEcCtD
Flunisolide—Dexamethasone—PTGS2—bone cancer	0.000157	0.0163	CrCbGaD
Flunisolide—Constipation—Doxorubicin—bone cancer	0.000157	0.00188	CcSEcCtD
Flunisolide—Pain—Doxorubicin—bone cancer	0.000157	0.00188	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—bone cancer	0.000157	0.00188	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—bone cancer	0.000157	0.00188	CcSEcCtD
Flunisolide—Hypersensitivity—Methotrexate—bone cancer	0.000156	0.00187	CcSEcCtD
Flunisolide—Asthenia—Methotrexate—bone cancer	0.000152	0.00182	CcSEcCtD
Flunisolide—Feeling abnormal—Doxorubicin—bone cancer	0.000151	0.00181	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—bone cancer	0.00015	0.0018	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—bone cancer	0.00015	0.00179	CcSEcCtD
Flunisolide—Hypersensitivity—Epirubicin—bone cancer	0.000146	0.00175	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—bone cancer	0.000146	0.00174	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—bone cancer	0.000145	0.00174	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—bone cancer	0.000145	0.00174	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—bone cancer	0.000145	0.00174	CcSEcCtD
Flunisolide—Asthenia—Epirubicin—bone cancer	0.000143	0.0017	CcSEcCtD
Flunisolide—Pruritus—Epirubicin—bone cancer	0.000141	0.00168	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—bone cancer	0.00014	0.00168	CcSEcCtD
Flunisolide—Diarrhoea—Epirubicin—bone cancer	0.000136	0.00162	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—bone cancer	0.000135	0.00162	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—bone cancer	0.000135	0.00161	CcSEcCtD
Flunisolide—Rash—Methotrexate—bone cancer	0.000134	0.0016	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—bone cancer	0.000134	0.0016	CcSEcCtD
Flunisolide—Headache—Methotrexate—bone cancer	0.000133	0.00159	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—bone cancer	0.000132	0.00158	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—bone cancer	0.000131	0.00157	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—bone cancer	0.00013	0.00155	CcSEcCtD
Flunisolide—Vomiting—Epirubicin—bone cancer	0.000126	0.00151	CcSEcCtD
Flunisolide—Nausea—Methotrexate—bone cancer	0.000126	0.00151	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—bone cancer	0.000126	0.0015	CcSEcCtD
Flunisolide—Rash—Epirubicin—bone cancer	0.000125	0.0015	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—bone cancer	0.000125	0.0015	CcSEcCtD
Flunisolide—Headache—Epirubicin—bone cancer	0.000124	0.00149	CcSEcCtD
Flunisolide—Dizziness—Doxorubicin—bone cancer	0.000122	0.00145	CcSEcCtD
Flunisolide—Nausea—Epirubicin—bone cancer	0.000118	0.00141	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—bone cancer	0.000117	0.0014	CcSEcCtD
Flunisolide—Rash—Doxorubicin—bone cancer	0.000116	0.00138	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—bone cancer	0.000116	0.00138	CcSEcCtD
Flunisolide—Headache—Doxorubicin—bone cancer	0.000115	0.00138	CcSEcCtD
Flunisolide—Nausea—Doxorubicin—bone cancer	0.000109	0.0013	CcSEcCtD
